Founded in 2002, SCP Vitalife Partners is a venture capital firm focused on life science investments in Israel and the U.S.

With $230 million under management in two funds, SCP Vitalife has made more than 30 investments in life sciences start-ups. We invest in companies with break-through products that address a current medical need and that are protected by strong IP.

With offices in Tel-Aviv and Philadelphia, our team includes seasoned professionals with backgrounds as entrepreneurs, senior operating executives, clinical practitioners and technologists. We provide hands-on assistance to our portfolio companies, leveraging our established strategic partner relationships to build highly successful companies.